Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
3,281.0
3.0 (0.09%)

 

  • STI Straits Times Index
    3,281.0
    3.0 (0.09%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,595.8
    7.9 (0.50%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    29,056.4
    173.4 (0.60%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,075.5
    1.4 (0.05%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    24,041.3
    108.1 (0.45%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    6,291.7
    5.6 (0.09%)
    Index delayed 10 minutes
  • KOR KOSPI
    2,250.6
    2.5 (0.11%)
    Index delayed 20 minutes
  • XAO XAO
    7,180.3
    21.7 (0.30%)
     

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 1,723.5M
  • Value: 1,021.1M
  • Rise: 204
  • Fall: 116
  • Unch: 499

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
AsiaPhos0.047+0.019
Golden Agri-Res0.235-
OEL0.029+0.009
Sincap0.013+0.003
Rex Intl0.192+0.011
AusGroup^0.048+0.001
BlackGoldNatural0.018+0.002
AsiaMedic0.013+0.002
Ley Choon0.022+0.004
GCCP0.009+0.002

World Indices

World Indices
Name Last Change
Nasdaq 9,388.9 +31.8
HSI 29,056.4 +173.4
HSCEI 11,419.9 +91.5
Jakarta 6,291.7 +5.6
Nikkei 225 24,041.3 +108.1
SSE Comp 3,075.5 +1.4
Shanghai A 3,222.5 +1.4
Shanghai B 260.1 +2.0
PSE Comp 0.0
KOSPI 2,250.6 +2.5

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

PERKINELMER INC PERKINELMER
Updated on 17 Jan 2020 (End of trading day)
Last (USD): 101.320 Change: +0.100 High: 101.820 Remarks: -
Change (%): +0.10 Low: 101.150
Open 101.590 Yesterday's Close 101.22
Buy Price - Sell Price -
Buy Volume (share) - Sell Volume (share) -
Cumulative Volume (share) 853,818 Cumulative Value
Click to show Stock Prices chart

Key Statistics

EPS (USD) a 2.14927 Trailing EPS (USD) e 2.10933 NAV (USD) b 24.3634
PE a 47.142 Trailing PE f 48.034 Price / NAV b 4.1587
Dividend (USD) d 0.278730 Cash In Hand (USD) g 3.5641 Issued & Paid-up Shares c 111,101,000
Dividend Yield (%) d 0.275 Price / Cash In Hand g 28.428 Treasury Shares h -
Beta - 75 Daysi 1.188 R-Squared - 75 Days(%)i 30.35 Market Cap (M) 11,256.753
Beta - 500 Daysi 1.127 R-Squared - 500 Days (%)i 32.87 Enterprise Value (M) 13,309.020
Piotroski F Score 6 Exchange Code PKI Par Value ( $ ) n.a.
52 Weeks Volatility (%) 23.10 Free Float (%) 99.1
Sector & Industry Health Technology - Medical Specialties
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 07 Nov 2019.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 13 Jul 2015.
  9. Beta and R-Squared are calculated in relation to the market index using the historical daily closing values of the stock and index as data points.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference PERKINELMER INC NYSE 11,256.753 47.142 48.034 4.1587 0.275
Industry Medical Specialties NYSE 31,127.388 44.575 42.461 4.8983 0.637
Local Peer MEDTRONIC PLC NYSE 159,545.431 34.452 34.171 3.1544 1.748
Local Peer ABBOTT LABORATORIES NYSE 157,298.600 66.850 48.089 4.9438 1.295
Local Peer THERMO FISHER SCIENTIFIC INC NYSE 136,012.137 46.294 37.865 4.6334 0.216
Local Peer DANAHER CORP NYSE 117,122.900 44.182 48.177 3.7901 0.383
Local Peer STRYKER CORP NYSE 79,436.448 22.358 23.186 6.4504 0.910
Local Peer BECTON DICKINSON & CO NYSE 74,939.057 - - - -
Local Peer BOSTON SCIENTIFIC CORP NYSE 61,718.350 36.935 56.622 6.3633 -
Local Peer EDWARDS LIFESCIENCES CORP NYSE 49,773.145 68.919 64.331 13.0474 -
Local Peer BAXTER INTERNATIONAL INC NYSE 45,812.190 28.209 28.958 5.8643 0.817
Local Peer ZIMMER BIOMET HOLDINGS INC NYSE 30,725.076 - - 2.5431 0.637
Local Peer RESMED INC NYSE 23,087.718 57.064 55.102 10.9046 0.946
Local Peer SMITH & NEPHEW ADR EACH REPR 2 ORD NYSE 21,566.149 32.583 30.913 4.3550 1.419
Other Local Peers METTLER-TOLEDO INTERNATIONAL INC (NYSE), TELEFLEX INC (NYSE), COOPER COS INC (NYSE), WATERS CORP (NYSE), VARIAN MEDICAL SYSTEMS INC (NYSE), STERIS PLC (NYSE), WEST PHARMACEUTICAL SERVICES INC (NYSE), BIO RAD LABORATORIES INC (NYSE), QIAGEN NV (NYSE), HILL-ROM HOLDINGS INC (NYSE), HAEMONETICS CORP (NYSE), PENUMBRA INC (NYSE), GLOBUS MED INC (NYSE), ENVISTA HOLDINGS CORPORATION (NYSE), NEVRO CORP (NYSE), CANTEL MEDICAL CORP (NYSE), GLAUKOS CORPORATION (NYSE), INSPIRE MEDICAL SYSTEMS INC (NYSE), AVANOS MEDICAL INC (NYSE), CRYOLIFE INC (NYSE), INVACARE CORP (NYSE), VAPOTHERM INC (NYSE), RA MEDICAL SYSTEMS INC (NYSE)
Global Peer INTUITIVE SURGICAL INC NASDAQ 69,347.867 61.484 52.772 8.9350 -
Global Peer IDEXX LABORATORIES INC NASDAQ 24,516.781 65.026 57.978 121.1171 -
Global Peer ALIGN TECHNOLOGY INC NASDAQ 22,122.809 55.275 52.811 16.9453 -
Global Peer DEXCOM INC NASDAQ 21,044.817 - - 27.5347 -
Global Peer GENMAB AS SPON ADS EACH REP 0.1 ORD SHS NASDAQ 14,804.562 63.535 64.011 8.1016 -
Global Peer HOLOGIC INC NASDAQ 14,565.636 - - 6.8846 -
Global Peer DENTSPLY SIRONA INC NASDAQ 13,335.943 - 82.118 2.6370 0.585
Global Peer INSULET CORPORATION NASDAQ 11,669.521 3,544.789 706.174 77.5036 -
Global Peer COCHLEAR LTD ASX 13,920.235 50.308 50.308 19.1766 1.368
Global Peer NOVOCURE LTD NASDAQ 9,162.550 - - 48.1310 -
Other Global Peers MASIMO CORPORATION (NASDAQ), FISHER & PAYKEL HEALTHCARE CORP (ASX), BRUKER CORPORATION (NASDAQ), ABIOMED INC (NASDAQ), WEIGAO GROUP (HKEx), INTEGRA LIFESCIENCES HLDGS CORP (NASDAQ), HARTA (Bursa), NUVASIVE INC (NASDAQ), TANDEM DIABETES CARE INC (NASDAQ), ICU MEDICAL INC (NASDAQ), WRIGHT MEDICAL GROUP NV (NASDAQ), NEOGEN CORP (NASDAQ), LIVANOVA PLC (NASDAQ), CONMED CORP (NASDAQ), QUIDEL CORP (NASDAQ), TOPGLOV (Bursa), Top Glove (SGX), EBOS GROUP (ASX), IRHYTHM TECHNOLOGIES INC (NASDAQ), MERIT MEDICAL SYSTEMS (NASDAQ), MICROPORT (HKEx), STAAR SURGICAL CO (NASDAQ), CARDIOVASCULAR SYSTEMS INC DEL (NASDAQ), BIOTELEMETRY INC (NASDAQ), AK MEDICAL (HKEx), ATRICURE INC (NASDAQ), NANOSONICS LIMITED (ASX), INMODE LTD (NASDAQ), SHOCKWAVE MEDICAL INC (NASDAQ), SILK ROAD MEDICAL INC (NASDAQ), ATRION CORP (NASDAQ), VAREX IMAGING CORPORATION (NASDAQ), NATUS MEDICAL INC (NASDAQ), MESA LABORATORIES INC (NASDAQ), TACTILE SYSTEMS TECHNOLOGY INC (NASDAQ), INOGEN INC (NASDAQ), AXONICS MODULATION TECHNLOGS INC (NASDAQ), VENUS MEDTECH-B (HKEx), CAREDX INC (NASDAQ), ACCELERATE DIAGNOSTICS INC (NASDAQ), CIRC (HKEx), ORTHOFIX MEDICAL INC (NASDAQ), LIFETECH SCI (HKEx), HESKA CORP (NASDAQ), ORTHOPEDIATRICS CORP (NASDAQ), VERICEL CORP (NASDAQ), LANTHEUS HOLDINGS INC (NASDAQ), LEMAITRE VASCULAR INC (NASDAQ), ANTARES PHARMA INC (NASDAQ), QUOTIENT LTD (NASDAQ), ANGIODYNAMICS INC (NASDAQ), CERUS CORP (NASDAQ), AXOGEN INC (NASDAQ), ESTABLISHMENT LABS HLDGS INC (NASDAQ), SURMODICS INC (NASDAQ), SI BONE INC (NASDAQ), ORASURE TECHNOLOGIES INC (NASDAQ), CUTERA INC (NASDAQ), VIEWRAY INC (NASDAQ), ALPHATEC HLDGS INC (NASDAQ), YESTAR HEALTH (HKEx), OXFORD IMMUNOTEC GLOBAL PLC (NASDAQ), SUPERMX (Bursa), MEDICAL DEVELOPMENT INTL (ASX), MCP INCOME OPPORTUNITIES TRUST (ASX), TRANSMEDICS GROUP INC (NASDAQ), CORMEDIX INC (NYSE American), SEASPINE HOLDINGS CORP (NASDAQ), INFUSYSTEM HOLDINGS INC (NYSE American), UTAH MEDICAL PRODUCTS (NASDAQ), SIENTRA INC (NASDAQ), ZYNEX INC (NASDAQ), STEREOTAXIS INC (NYSE American), BIOLIFE SOLUTIONS INC (NASDAQ), INOVIO PHARMACEUTICALS INC (NASDAQ), RTI SURGICAL HOLDINGS INC (NASDAQ), MISONIX INC (NASDAQ), IRADIMED CORP (NASDAQ), FLUIDIGM CORP DEL (NASDAQ), GOLDEN MEDITECH (HKEx), PULSE BIOSCIENCES INC (NASDAQ), ACCURAY INCORPORATED (NASDAQ), PW MEDTECH (HKEx), AVADEL PHARMACEUTICALS PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), GENMARK DIAGNOSTICS INC (NASDAQ), VOLPARA HEALTH TECHNOLOGIES LTD (ASX), APYX MEDICAL CORPORATION (NASDAQ), KDL MEDICAL (HKEx), SOLITON INC (NASDAQ), REPRO MEDSYSTEMS INC (NASDAQ), NYMOX PHARMACEUTICALS CORP(BAHAMAS) (NASDAQ), MODERN DENTAL (HKEx), ITAMAR MEDICAL LTD SPON ADS EACH REP 30 ORD SHS (NASDAQ), VENUS CONCEPT INC (NASDAQ), TELA BIO INC (NASDAQ), INTRICOM CORP (NASDAQ), ROCKWELL MEDICAL INC (NASDAQ), PROFOUND MED CORP (NASDAQ), CYTOSORBENTS CORP (NASDAQ), FONAR CORP (NASDAQ), DERMTECH INC (NASDAQ), BRAINSWAY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), MY MEDICARE (HKEx), SOLENO THERAPEUTICS INC (NASDAQ), SOMNOMED LIMITED (ASX), BIOSIG TECHNOLOGIES INC (NASDAQ), YUNNAN ENERGY (HKEx), ONCOCYTE CORP (NYSE American), ENLIVEX THERAPEUTICS LTD (NASDAQ), CONFORMIS INC (NASDAQ), MRI INTERVENTIONS INC (NASDAQ), COMPUMEDICS (ASX), NEURONETICS INC (NASDAQ), SECOND SIGHT MEDICAL PRODUCTS INC (NASDAQ), ELECTROMED INC (NYSE American), RESONANCE HEALTH LTD (ASX), NEMAURA MEDICAL INC (NASDAQ), ELLEX MEDICAL LASERS LTD (ASX), NEPHROS INC (NASDAQ), SDI LTD (ASX), STRATA SKIN SCIENCES INC (NASDAQ), SENSUS HEALTHCARE INC (NASDAQ), CHEMBIO DIAGNOSTICS INC (NASDAQ), HELIUS MEDICAL TECHNOLOGIES INC (NASDAQ), CYCLOPHARM LIMITED (ASX), MOTUS GI HOLDINGS INC (NASDAQ), KELFRED (HKEx), COLLPLANT BIOTECHNOLOGIES LTD SPON ADS EACH REP 1 ORD SHS (NASDAQ), APOLLO ENDOSURGERY INC (NASDAQ), PAVMED INC (NASDAQ), IMPEDIMED LIMITED (ASX), MILESTONE SCIENTIFIC INC (NYSE American), ALPHA PRO TECH (NYSE American), RETRACTABLE TECHNOLOGIES INC (NYSE American), ADMEDUS LTD (ASX), VINCENT MED (HKEx), IRIDEX CORP (NASDAQ), Biolidics (SGX), ELECTROCORE INC (NASDAQ), DAXOR CORP (NYSE American), CELSION CORPORATION (NASDAQ), OVENTUS MEDICAL LTD (ASX), ENDOLOGIX INC (NASDAQ), IMMUCELL CORP (NASDAQ), EMVISION MEDICAL DEVICES LTD (ASX), IMPRESSION HEALTHCARE LIMITED (ASX), Yunnan Energy (SGX), EKSO BIONICS HOLDINGS INC (NASDAQ), ZOSANO PHARMA CORP (NASDAQ), BIOMERICA INC (NASDAQ), NEOVASC INC (NASDAQ), RESPIRI LTD (ASX), MICRO-X LTD (ASX), LBT INNOVATIONS LTD (ASX), XTANT MEDICAL HLDGS INC (NYSE American), BELLEROPHON THERAPEUTICS INC (NASDAQ), LIFE HEALTHCARE (HKEx), TRINITY BIOTECH PLC ADR EACH REPR 4 CLS A ORD USD0.019 (NASDAQ), NANOVIBRONIX INC (NASDAQ), BIOLASE INC (NASDAQ), ADVENTA (Bursa), UNIVERSAL BIOSENSORS INC NPV (CDI) (ASX), Medtecs Intl (SGX), TITAN MEDICAL INC (NASDAQ), UG Healthcare (SGX), OBJ LIMITED (ASX), DARIOHEALTH CORP (NASDAQ), DIMERIX LTD (ASX), LKL (Bursa), CHECK-CAP LTD (NASDAQ), CARDIEX LTD (ASX), NEUROTROPE INC (NASDAQ), REWALK ROBOTICS LTD (NASDAQ), CYANOTECH CORP (NASDAQ), OBALON THERAPEUTICS INC (NASDAQ), USCOM LTD (ASX), ATOSSA THERAPEUTICS INC (NASDAQ), ALLEGRA ORTHOPAEDICS LIMITED (ASX), PREDICTIVE ONCOLOGY INC (NASDAQ), THERMOGENESIS HOLDINGS INC (NASDAQ), Annica (SGX), OPTISCAN IMAGING (ASX), COMBEST HOLD (HKEx), AVINGER INC (NASDAQ), HANCOCK JAFFE LABORATORIES INC (NASDAQ), INSPIREMD INC (NYSE American), IMAGION BIOSYSTEMS LIMITED (ASX), LIANLUO SMART LIMITED (NASDAQ), OSPREY MEDICAL INC NPV (CHESS DEPOSITARY INTERESTS) (ASX), TENAX THERAPEUTICS INC (NASDAQ), DYNATRONICS CORP (NASDAQ), ANALYTICA (ASX), HUAKANG BIOMED (HKEx), MEDIGUS SPON ADS EACH REP 50 ORD SHS (POST SPLT) (NASDAQ), MICRON SOLUTIONS INC (NYSE American), AETHLON MEDICAL INC (NASDAQ), VALERITAS HOLDINGS INC (NASDAQ), ALLIED HEALTHCARE PRODUCTS INC (NASDAQ), DIGIRAD CORP (NASDAQ), STHAI (SET), CHF SOLUTIONS INC (NASDAQ), CH DEMETER FIN (HKEx), NEUROMETRIX INC (NASDAQ), ADHERIUM LIMITED (ASX), VIVEVE MEDICAL INC (NASDAQ), SINTX TECHNOLOGIES INC (NASDAQ), METALICITY LIMITED (ASX), MEDIGARD LIMITED (ASX), AKERS BIOSCIENCES INC (NASDAQ), NEUROTECH INTERNATIONAL LTD (ASX)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days 0.070+0.980
+1.05 %
10 Days 0.070+4.330
+4.54 %
20 Days 0.070+4.760
+5.00 %
Medium Term Return 3 Months 0.070+18.220
+22.01 %
6 Months 0.140+7.490
+8.13 %
1 Year 0.280+14.920
+17.59 %
Long Term Return 2 Years 0.560+20.460
+26.00 %
3 Years 0.840+49.610
+97.56 %
5 Years 1.330+57.030
+131.77 %
Annualised Return Annualised --
+18.31 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 78.350 - 103.000 Change From 1 Year Low +22.970 % Change From 1 Year Low (%) +29.32
Change From 1 Year High -1.680 % Change From 1 Year High (%) -1.63
2 Years Range 70.740 - 103.000 Change From 2 Years Low +30.580 % Change From 2 Years Low (%) +43.23
Change From 2 Years High -1.680 % Change From 2 Years High (%) -1.63
5 Years Range 39.500 - 103.000 Change From 5 Years Low +61.820 % Change From 5 Years Low (%) +156.51
Change From 5 Years High -1.680 % Change From 5 Years High (%) -1.63
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

PerkinElmer, Inc. engages in the provision of products, services, and solutions for diagnostics, food, environmental, life sciences, and applied markets. It operates through the following two segments: Discovery & Analytical Solutions, and Diagnostics. The Discovery & Analytical Solutions segment comprises of technologies that help life sciences researchers better understand diseases and develop treatments. The Diagnostics segment offers instruments, reagents, assay platforms, and software to hospitals, medical labs, clinicians, and medical research professionals to help improve the health of families. The company was founded by Richard Scott Perkin and Charles W. Elmer on April 19, 1937 and is headquartered in Waltham, MA.

Historical Price Data

Date Open High Low Close Volume VWAP
17 Jan 2020 101.590 101.820 101.150 101.320 853,818 -
16 Jan 2020 102.110 102.300 100.860 101.220 566,990 -
15 Jan 2020 101.710 102.455 101.560 101.730 377,724 -
14 Jan 2020 100.210 102.060 100.210 101.690 782,101 -
13 Jan 2020 100.380 100.950 99.920 100.630 398,180 -
10 Jan 2020 100.000 101.160 99.710 100.340 471,256 -
09 Jan 2020 99.220 99.910 98.620 99.860 445,352 -
08 Jan 2020 98.840 99.740 97.260 98.590 597,643 -
07 Jan 2020 97.730 98.990 97.275 98.800 441,844 -
06 Jan 2020 96.370 98.050 96.050 98.000 464,668 -
03 Jan 2020 96.710 97.680 95.770 96.990 558,920 -
02 Jan 2020 98.250 98.860 97.683 98.860 708,876 -
31 Dec 2019 96.640 97.320 96.529 97.100 344,260 -
30 Dec 2019 97.090 97.100 96.305 96.660 228,466 -
27 Dec 2019 97.300 97.300 96.610 97.050 321,931 -
26 Dec 2019 97.590 97.650 96.860 97.170 298,318 -
24 Dec 2019 97.410 97.530 96.750 97.450 101,998 -
23 Dec 2019 96.900 97.270 96.400 97.210 277,971 -
20 Dec 2019 96.220 96.770 95.480 96.560 778,312 -
19 Dec 2019 94.840 96.190 94.680 95.700 426,323 -
18 Dec 2019 95.080 95.250 94.400 94.650 336,520 -
17 Dec 2019 96.110 96.300 94.910 95.190 346,638 -
Summary
Current 2 Weeks
(06 Jan 2020 to 17 Jan 2020)
96.370 102.455 96.050 101.320 5,399,576 -
Previous 2 Weeks
(19 Dec 2019 to 03 Jan 2020)
94.840 102.455 94.680 96.990 4,045,375 -
4 Weeks from
(20 Nov 2019 to 18 Dec 2019)
90.750 102.455 89.970 94.650 9,438,737 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.